
Lupin Ltd. Sees Significant Open Interest Surge Signalling Renewed Market Optimism
2026-05-12 12:00:12Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, reflecting heightened market activity and shifting investor positioning. The stock outperformed its sector and broader indices on 12 May 2026, signalling renewed bullish sentiment amid evolving volume and price dynamics.
Read full news article
Lupin Ltd. Sees Sharp Open Interest Surge Signalling Renewed Market Optimism
2026-05-12 11:00:11Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, reflecting heightened market participation and potential directional bets. The stock’s latest open interest rose by 17.74% to 56,371 contracts, up from 47,878 previously, signalling increased investor interest amid a backdrop of mixed price action and sectoral trends.
Read full news article
Lupin Ltd. Sees Sharp Open Interest Surge Signalling Renewed Market Interest
2026-05-12 10:00:11Lupin Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, reflecting a shift in market positioning and investor sentiment. The 17.9% increase in OI alongside rising volumes suggests heightened speculative activity and potential directional bets on the stock’s near-term trajectory.
Read full news article
Lupin Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals
2026-05-12 08:04:52Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent 5.56% decline in its share price to ₹2,245.65 on 12 May 2026, the stock’s longer-term technical indicators and fundamental mojo score suggest a cautiously optimistic outlook for investors.
Read full news article
Lupin Ltd. Sees Sharp Open Interest Surge Amid Volatile Trading
2026-05-11 15:00:09Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 19.5% surge in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent price underperformance. This development reflects evolving market positioning and potential directional bets amid a backdrop of mixed technical signals and rising investor participation.
Read full news article
Lupin Ltd. Sees Sharp Open Interest Surge Amid Volatile Derivatives Activity
2026-05-11 14:00:08Lupin Ltd., a mid-cap pharmaceutical heavyweight, experienced a notable 17.3% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent price underperformance. This surge in open interest, coupled with volume patterns and shifting investor positioning, offers critical insights into potential directional bets and market sentiment for the stock.
Read full news article
Lupin Ltd. Sees Sharp Open Interest Surge Amid Derivatives Market Activity
2026-05-11 13:00:07Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a notable 16.2% increase in open interest (OI) in its derivatives segment on 11 May 2026, signalling heightened market activity despite the stock’s recent price underperformance. This surge in OI, coupled with volume patterns and shifting investor positioning, offers critical insights into potential directional bets and market sentiment surrounding the stock.
Read full news article
Lupin Ltd. Sees Sharp Open Interest Surge Amid Volatile Derivatives Activity
2026-05-11 12:00:07Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the stock’s derivatives market shows signs of increased speculative interest, raising questions about potential directional bets and future price movements.
Read full news article
Lupin Ltd. Sees Sharp Open Interest Surge Amidst Volatile Trading
2026-05-11 11:00:08Lupin Ltd., a mid-cap pharmaceutical heavyweight, has witnessed a notable surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the stock’s derivatives market reveals complex directional bets that merit close attention from traders and investors alike.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
09-May-2026 | Source : BSECopy of Newspaper Publication regarding Audited Financial Results of the Company for the quarter and year ended March 31 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
08-May-2026 | Source : BSEAudio recording of the Earnings Call - Q4 FY26
Announcement under Regulation 30 (LODR)-Press Release / Media Release
07-May-2026 | Source : BSELupin FY2026 and Q4 FY2026 Results
Corporate Actions
No Upcoming Board Meetings
Lupin Ltd. has declared 600% dividend, ex-date: 25 Jul 25
Lupin Ltd. has announced 2:10 stock split, ex-date: 27 Aug 10
Lupin Ltd. has announced 1:1 bonus issue, ex-date: 11 Aug 06
No Rights history available






